Toulose, France Clinical Trials

A listing of Toulose, France clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
I am looking for
added new label for I am looking for
Advanced Filters
Found 129 clinical trials
EXCELLENT (EXpanded CELL ENdocardiac Transplantation)

A multicentric controlled phase I / IIb study evaluating the safety and the efficacy of in vitro expanded peripheral blood CD34+ stem cells output by the StemXpand Automated Process, and injected in patients with an acute myocardial infarction and a LVEF remaining below 50% after reperfusion versus standard of care.

ejection fraction
coronary angioplasty
CHU Montpellier Arnaud-De-Villeneuve
 (121.2 away) Contact site
  • 11 Jul, 2021
  • +12 other locations
MALIBU Trial - Combination of Ibrutinib and Rituximab in Untreated Marginal Zone Lymphomas

Single-arm, phase II clinical trial of patients with Extranodal Marginal Zone Lymphoma (EMZL). It is planned to recruit 130 patients. Additional patients with Splenic Marginal Zone Lymphoma (SMZL), up to 30, and Nodal Marginal Zone Lymphoma (NMZL), up to 15, will be included in the trial in order to preliminary …

marginal zone lymphoma
gastric malt lymphoma
IUCT Oncopole Toulouse
 (3.8 away) Contact site
  • 16 Jun, 2021
  • +53 other locations
A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2)

This study will assess the antitumor activity, safety, tolerability, and pharmacokinetics (PK) of the Mesenchymal-epithelial Transition Factor (MET) inhibitor tepotinib combined with the 3rd generation EGFR inhibitor osimertinib in participants with advanced or metastatic non-small cell lung cancer (NSCLC).

epidermal growth factor receptor
epidermal growth factor
stage iv non-small cell lung cancer
lung carcinoma
CHU de Toulouse - H pital Larrey - Service de Pneumologie et Oncologie Pneumologique
 (0.0 away) Contact site
  • 01 Aug, 2021
  • +174 other locations
A Study of Daratumumab Monotherapy in Previously Untreated Patients With Stage 3B Light Chain (AL) Amyloidosis

This is an open-label, multicenter, Phase 2 study in subjects with newly diagnosed stage 3B light chain (AL) amyloidosis.

Hopitaux Universitaires Henri-Mondor
 (360.2 away) Contact site
  • 11 Feb, 2021
  • +4 other locations
Study to Gather Information About Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following a Recent Non Cardioembolic Ischemic Stroke Which Occurs When a Blood Clot Has Formed Somewhere in the Human Body (But Not in the Heart) Travelled to the Brain.

The purpose of this study is to try to find the best dose of the new drug BAY 2433334 to give to participants and to look at how well BAY 2433334 works on top of antiplatelet therapy in patients following a recent non cardioembolic ischemic stroke which occurs when a …

H pital Pellegrin - Bordeaux
 (131.2 away) Contact site
  • 12 Jul, 2021
  • +261 other locations
TAK-018 for Prevention of the Recurrence of Postoperative Crohn's Disease (CD)

The purpose of this study is to evaluate the efficacy of TAK-018 in reducing endoscopic recurrence of intestinal inflammation in postoperative participants with CD after a planned laparoscopic ileocecal resection with primary anastomosis.

antibiotic therapy
tumour necrosis
tumor necrosis factor
tumor necrosis factor alpha
Centre Hospitalier Universitaire Estaing
 (169.8 away) Contact site
  • 18 Jul, 2021
  • +63 other locations
A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa

This study is open to adults with a chronic inflammatory skin disease called hidradenitis suppurativa. The purpose of this study is to find out whether a medicine called spesolimab helps people with moderate to severe hidradenitis suppurativa. Participants are put into 2 groups by chance. One group takes spesolimab. The …

Hospital Santa Creu i Sant Pau
 (155.0 away) Contact site
  • 01 Aug, 2021
  • +24 other locations
A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

The purpose of this study is evaluate the efficacy of teclistamab at the recommended Phase 2 dose (RP2D).

multiple myeloma
measurable disease
P le IUC Oncopole CHU
 (0.5 away) Contact site
  • 31 May, 2021
  • +69 other locations
A Phase 2 Study to Evaluate Efficacy and Safety of AL002 in Participants With Early Alzheimer's Disease

A phase 2 randomized, double blind, placebo controlled study evaluating the efficacy and safety of AL002 in participants with Early Alzheimer's Disease.

mini-mental state examination
alzheimer's disease
Hospital de La Santa Creu i Sant Pau
 (154.7 away) Contact site
  • 29 Jul, 2021
  • +85 other locations
Trastuzumab Deruxtecan in Participants With HER2-mutated Metastatic Non-small Cell Lung Cancer (NSCLC)

This study was designed to evaluate the safety and efficacy of trastuzumab deruxtecan in HER2-mutated metastatic non-small cell lung cancer (NSCLC) participants who had disease recurrence or progression during/after at least one regimen of prior anticancer therapy (second line or later) that must have contained a platinum-based chemotherapy drug.

liquid biopsy
platinum-based chemotherapy
lung carcinoma
measurable disease
cancer chemotherapy
Hospital Universitario Vall d'Hebron
 (153.9 away) Contact site
  • 18 Jul, 2021
  • +52 other locations